These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25176325)

  • 1. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.
    Boehm LM; Jayakrishnan TT; Miura JT; Zacharias AJ; Johnston FM; Turaga KK; Gamblin TC
    J Surg Oncol; 2015 Feb; 111(2):213-20. PubMed ID: 25176325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes.
    Kim JH; Yoon HK; Sung KB; Ko GY; Gwon DI; Shin JH; Song HY
    Cancer; 2008 Oct; 113(7):1614-22. PubMed ID: 18704990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
    Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
    J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis.
    Mosconi C; Solaini L; Vara G; Brandi N; Cappelli A; Modestino F; Cucchetti A; Golfieri R
    Cardiovasc Intervent Radiol; 2021 May; 44(5):728-738. PubMed ID: 33709272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
    Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
    Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.
    Al-Adra DP; Gill RS; Axford SJ; Shi X; Kneteman N; Liau SS
    Eur J Surg Oncol; 2015 Jan; 41(1):120-7. PubMed ID: 25449754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis.
    Edeline J; Lamarca A; McNamara MG; Jacobs T; Hubner RA; Palmer D; Groot Koerkamp B; Johnson P; Guiu B; Valle JW
    Cancer Treat Rev; 2021 Sep; 99():102258. PubMed ID: 34252720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
    Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.
    Hyder O; Marsh JW; Salem R; Petre EN; Kalva S; Liapi E; Cosgrove D; Neal D; Kamel I; Zhu AX; Sofocleous CT; Geschwind JF; Pawlik TM
    Ann Surg Oncol; 2013 Nov; 20(12):3779-86. PubMed ID: 23846786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Resection Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical Resection with Intra-Arterial Therapies.
    Wright GP; Perkins S; Jones H; Zureikat AH; Marsh JW; Holtzman MP; Zeh HJ; Bartlett DL; Pingpank JF
    Ann Surg Oncol; 2018 Jan; 25(1):83-90. PubMed ID: 29063296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma.
    Hong K; Geschwind JF
    Semin Oncol; 2010 Apr; 37(2):110-7. PubMed ID: 20494703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.
    Camacho JC; Kokabi N; Xing M; Schuster DM; Kim HS
    Clin Nucl Med; 2014 Nov; 39(11):944-50. PubMed ID: 25140563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional and drug-eluting beads transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a systematic review and pooled analysis.
    He M; Jiang N; Yin X; Xu A; Mu K
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):531-540. PubMed ID: 36402872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results.
    Aliberti C; Benea G; Tilli M; Fiorentini G
    Cardiovasc Intervent Radiol; 2008; 31(5):883-8. PubMed ID: 18478290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.
    Burger I; Hong K; Schulick R; Georgiades C; Thuluvath P; Choti M; Kamel I; Geschwind JF
    J Vasc Interv Radiol; 2005 Mar; 16(3):353-61. PubMed ID: 15758131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial locoregional therapies for intrahepatic cholangiocarcinoma.
    Patel S; Hasanain A; Fang A; Khavandi MM; Mathias T; Cohen EI; Etezadi V; Sabri SS; Camacho JC; Yarmohammadi H; Banovac F; He AR; Radkani P; Habibollahi P; Nezami N
    Expert Rev Gastroenterol Hepatol; 2024 Sep; 18(9):505-519. PubMed ID: 39246149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis.
    Zacharias AJ; Jayakrishnan TT; Rajeev R; Rilling WS; Thomas JP; George B; Johnston FM; Gamblin TC; Turaga KK
    PLoS One; 2015; 10(10):e0139940. PubMed ID: 26448327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
    Kuhlmann JB; Euringer W; Spangenberg HC; Breidert M; Blum HE; Harder J; Fischer R
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):437-43. PubMed ID: 22261548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current role of portal vein embolization/hepatic artery chemoembolization.
    Kokudo N; Makuuchi M
    Surg Clin North Am; 2004 Apr; 84(2):643-57. PubMed ID: 15062666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
    Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.